shares on issue, page-69

Anyone who has a google news notification on Arixtra should have been notified about this article last night http://www.myiris.com/newsCentre/storyShow.php?fileR=20111214142300199&dir=2011/12/14

The relevant bits:

"DRRD was able to garner an 8.8% market share in generic Arixtra (USD 340 million), while the Apotex (AG) had 68.2% market share for week ended 25 Nov 2011. This is a negative surprise as we were expecting a market share of 30-40% for DRRD."

"Management expects market share gains as production yields improve."

Note that this is almost identical wording to an October statement by Nomura on Myiris with data to 23 September (http://www.myiris.com/newsCentre/storyShow.php?fileR=20111012132606199&dir=2011/10/12&secID=livenews) except that at that time DRRD market share was 7.4%.